A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

December 22, 2014
Major Pharmacy Group Will Prioritize AbbVie’s Hep C Regimen
The pharmacy benefit manager Express Scripts has will only reimburse for AbbVie’s hepatitis C regimen for people with genotype 1 of the virus.
Heterosexuals at High Risk for HIV Don’t Test Enough
Low socioeconomic status heterosexuals in major U.S. urban areas often engage in sex that puts them at risk for HIV, but do not get tested at high enough rates.
December 19, 2014
Financial Incentives for Undetectable Viral Load Are Well Received
A U.S. program offering $70 gift cards for each undetectable viral load test was well liked by both its HIV-positive participants and the clinic staff in a trial.
FDA Approves AbbVie's Hepatitis C Regimen Viekira Pak
The U.S. Food and Drug Administration has approved AbbVie's Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat hepatitis C virus (HCV) genotype 1.
December 18, 2014
HIV and Reduced Physical Function Linked to Higher Risk of Death
HIV infection as well as reduced physical function in middle age each contribute to a raised mortality risk.
December 17, 2014
Gay and Bi Men Drive 10 Percent Rise in U.S. Syphilis Rate
The U.S. syphilis rate is continuing its steady climb, with men who have sex with men (MSM) driving a 10 percent increase between 2012 and 2013.
December 16, 2014
HIV Actually Appears to Have Strengthened, at Least in Europe
HIV’s virulence seems to have gathered steam over time, according to a large study of the epidemic in Europe.
December 15, 2014
Hepatitis C Linked to Accelerated Immune Cell Differentiation
Hepatitis C is linked to accelerated differentiation of CD4 and CD8 cells—major building blocks of the immune system—into specific phenotypes.
People With HIV and Lymphoma Shouldn’t Be Barred From Transplants
HIV-positive people with lymphoma should no longer be excluded from receiving stem cell transplants, nor should their treatment be restricted to certain clinics.
December 12, 2014
Pushing PrEP in HIV 'Hot Zones' Better Combats the Virus
Targeting “hot zones” where the HIV epidemic is more severe and individuals’ risk-taking is high is a much more effective way to roll out the use of PrEP.
December 11, 2014
FDA OKs Wider Use of Rapid Test That Better Detects Early HIV
The FDA has granted permission for more widespread use of a rapid test that can detect HIV earlier after infection than standard antibody tests. 
December 10, 2014
45% of PrEP Users at SF Clinic Report Using Condoms Less Often
A survey of PrEP users at a San Francisco hospital found that 45 percent reported using condoms less frequently since starting Truvada.
December 09, 2014
HIV Meds May Treat Major Cause of Blindness
Nucleoside reverse transcriptase inhibitors for HIV may be used to treat age-related macular degeneration, a leading cause of blindness, and to treat other disorders related to inflammation.
December 08, 2014
UK’s Gay Men Should Receive HPV Vaccination, Says Expert Panel
The United Kingdom Joint Committee on Vaccination and Immunisation has recommended that gay and bi men receive the HPV vaccination.
December 05, 2014
HIV May Be Evolving Into a Weaker Virus
As HIV has evolves to evade the particulars of humans’ immune systems, it may be becoming less virulent, at least in Botswana.
December 04, 2014
CDC Proposes Advising That Male Circumcision Helps Prevent HIV
The CDC is considering suggesting that clinicians advise teenage boys, men and parents of newborn boys that circumcision lowers the risk of HIV transmission from females to males.
December 03, 2014
Europe and Central Asia Are Failing to Curb the HIV Epidemic
New diagnoses of HIV in Europe and Central Asia increased by 80 percent between 2004 and 2013, from 76,000 to 136,000 diagnoses.
December 02, 2014
Conceiving a Child on Truvada as PrEP Appears Safe
Taking Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) until shortly after conception of a child appears safe.
December 01, 2014
Starting HIV Meds Within a Year of Infection Helps Restore CD4s
Beginning treatment for HIV within a year of infection improves the likelihood of returning an individual’s CD4 count to a normal level.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.